| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ANGPT1
|
angiopoietin 1
|
|
ANOS1
|
anosmin 1
|
|
ANXA2
|
annexin A2
|
|
APITD1
|
apoptosis-inducing, TAF9-like domain 1
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP10
|
aquaporin 10
|
|
AQP9
|
aquaporin 9
|
|
ARHGAP15
|
Rho GTPase activating protein 15
|
|
ARIH2
|
ariadne RBR E3 ubiquitin protein ligase 2
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ATG5
|
autophagy related 5
|
|
ATG7
|
autophagy related 7
|
|
ATR
|
ATR serine/threonine kinase
|
|
AUP1
|
ancient ubiquitous protein 1
|
|
AURKB
|
aurora kinase B
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BECN1
|
beclin 1, autophagy related
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BSG
|
basigin (Ok blood group)
|
|
BTG2
|
BTG family, member 2
|
|
C19ORF40
|
chromosome 19 open reading frame 40
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA2
|
carbonic anhydrase II
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CC2D1B
|
coiled-coil and C2 domain containing 1B
|
|
CCDC101
|
coiled-coil domain containing 101
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
|
CCNA2
|
cyclin A2
|
|
CCS
|
copper chaperone for superoxide dismutase
|
|
CD163
|
CD163 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD207
|
CD207 molecule, langerin
|
|
CD274
|
CD274 molecule
|
|
CD38
|
CD38 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2AIP
|
CDKN2A interacting protein
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CENPI
|
centromere protein I
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CLOCK
|
clock circadian regulator
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CTH
|
cystathionine gamma-lyase
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSA
|
cathepsin A
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSL
|
cathepsin L
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYTH1
|
cytohesin 1
|
|
DAAM1
|
dishevelled associated activator of morphogenesis 1
|
|
DCHS2
|
dachsous cadherin-related 2
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DGAT1
|
diacylglycerol O-acyltransferase 1
|
|
DHX36
|
DEAH (Asp-Glu-Ala-His) box polypeptide 36
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLX5
|
distal-less homeobox 5
|
|
DNAJB11
|
DnaJ (Hsp40) homolog, subfamily B, member 11
|
|
DNM2
|
dynamin 2
|
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
DUOXA2
|
dual oxidase maturation factor 2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP15
|
dual specificity phosphatase 15
|
|
DUSP22
|
dual specificity phosphatase 22
|
|
DUSP23
|
dual specificity phosphatase 23
|
|
DUSP3
|
dual specificity phosphatase 3
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYRK3
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EP300
|
E1A binding protein p300
|
|
EP400
|
E1A binding protein p400
|
|
EPHA2
|
EPH receptor A2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FBLN5
|
fibulin 5
|
|
FBXL2
|
F-box and leucine-rich repeat protein 2
|
|
FBXO32
|
F-box protein 32
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFBP1
|
fibroblast growth factor binding protein 1
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHL1
|
four and a half LIM domains 1
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FPR1
|
formyl peptide receptor 1
|
|
FRMD5
|
FERM domain containing 5
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FXN
|
frataxin
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GEN1
|
GEN1 Holliday junction 5' flap endonuclease
|
|
GFER
|
growth factor, augmenter of liver regeneration
|
|
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1
|
|
GGA2
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 2
|
|
GGA3
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 3
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GMCL1
|
germ cell-less, spermatogenesis associated 1
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GPHA2
|
glycoprotein hormone alpha 2
|
|
GPHB5
|
glycoprotein hormone beta 5
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HMGB1
|
high mobility group box 1
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICK
|
intestinal cell (MAK-like) kinase
|
|
IER3
|
immediate early response 3
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IHH
|
indian hedgehog
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL15
|
interleukin 15
|
|
IL16
|
interleukin 16
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3
|
interleukin 3
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB5
|
integrin, beta 5
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KAZN
|
kazrin, periplakin interacting protein
|
|
KCNJ13
|
potassium channel, inwardly rectifying subfamily J, member 13
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLC4
|
kinesin light chain 4
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT8
|
keratin 8, type II
|
|
LAT
|
linker for activation of T cells
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHX2
|
LIM homeobox 2
|
|
LIMK1
|
LIM domain kinase 1
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMNA
|
lamin A/C
|
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
MAN2C1
|
mannosidase, alpha, class 2C, member 1
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP9
|
microtubule-associated protein 9
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MCFD2
|
multiple coagulation factor deficiency 2
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
ME3
|
malic enzyme 3, NADP(+)-dependent, mitochondrial
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFAP2
|
microfibrillar-associated protein 2
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR152
|
microRNA 152
|
|
MIR17
|
microRNA 17
|
|
MIR21
|
microRNA 21
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR34A
|
microRNA 34a
|
|
MIR939
|
microRNA 939
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSRA
|
methionine sulfoxide reductase A
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYO10
|
myosin X
|
|
MYO7A
|
myosin VIIA
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCSTN
|
nicastrin
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NDUFAB1
|
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa
|
|
NELFE
|
negative elongation factor complex member E
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFS1
|
NFS1 cysteine desulfurase
|
|
NFYC
|
nuclear transcription factor Y, gamma
|
|
NLRP6
|
NLR family, pyrin domain containing 6
|
|
NME4
|
NME/NM23 nucleoside diphosphate kinase 4
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRP1
|
neuropilin 1
|
|
NSF
|
N-ethylmaleimide-sensitive factor
|
|
NUCB1
|
nucleobindin 1
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PDCD1
|
programmed cell death 1
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PF4
|
platelet factor 4
|
|
PHB
|
prohibitin
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIM3
|
Pim-3 proto-oncogene, serine/threonine kinase
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLG
|
plasminogen
|
|
PLK1
|
polo-like kinase 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PLXNB1
|
plexin B1
|
|
PMEL
|
premelanosome protein
|
|
PML
|
promyelocytic leukemia
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
PON1
|
paraoxonase 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRNP
|
prion protein
|
|
PROM1
|
prominin 1
|
|
PRTN3
|
proteinase 3
|
|
PSEN1
|
presenilin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PXN
|
paxillin
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAB32
|
RAB32, member RAS oncogene family
|
|
RAG1
|
recombination activating gene 1
|
|
RANBP2
|
RAN binding protein 2
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASAL1
|
RAS protein activator like 1 (GAP1 like)
|
|
RBM4
|
RNA binding motif protein 4
|
|
RDH10
|
retinol dehydrogenase 10 (all-trans)
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RELN
|
reelin
|
|
REN
|
renin
|
|
RGCC
|
regulator of cell cycle
|
|
RGS3
|
regulator of G-protein signaling 3
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RNF14
|
ring finger protein 14
|
|
RNF2
|
ring finger protein 2
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SARM1
|
sterile alpha and TIR motif containing 1
|
|
SCTR
|
secretin receptor
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEPT4
|
septin 4
|
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SGPL1
|
sphingosine-1-phosphate lyase 1
|
|
SH3BP1
|
SH3-domain binding protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC17A5
|
solute carrier family 17 (acidic sugar transporter), member 5
|
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC35C1
|
solute carrier family 35 (GDP-fucose transporter), member C1
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLFN5
|
schlafen family member 5
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD7
|
SMAD family member 7
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SOST
|
sclerostin
|
|
SOX6
|
SRY (sex determining region Y)-box 6
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRY
|
sex determining region Y
|
|
SSBP1
|
single-stranded DNA binding protein 1, mitochondrial
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STRA13
|
stimulated by retinoic acid 13
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAOK1
|
TAO kinase 1
|
|
TBX2
|
T-box 2
|
|
TBX3
|
T-box 3
|
|
TBX5
|
T-box 5
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
|
TICRR
|
TOPBP1-interacting checkpoint and replication regulator
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNK1
|
tyrosine kinase, non-receptor, 1
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOLLIP
|
toll interacting protein
|
|
TOP3A
|
topoisomerase (DNA) III alpha
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPCN2
|
two pore segment channel 2
|
|
TPO
|
thyroid peroxidase
|
|
TPPP
|
tubulin polymerization promoting protein
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRO
|
trophinin
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TYMP
|
thymidine phosphorylase
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
ULK3
|
unc-51 like kinase 3
|
|
URM1
|
ubiquitin related modifier 1
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
UXT
|
ubiquitously-expressed, prefoldin-like chaperone
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VTI1B
|
vesicle transport through interaction with t-SNAREs 1B
|
|
VTRNA2-1
|
vault RNA 2-1
|
|
WARS2
|
tryptophanyl tRNA synthetase 2, mitochondrial
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XAF1
|
XIAP associated factor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
YY1
|
YY1 transcription factor
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZNF350
|
zinc finger protein 350
|
